← Evidence map

ReviewHuman vaccines & immunotherapeutics2016

Emerging anti-cancer antibodies and combination therapies targeting HER3/ERBB3.

Nadège Gaborit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

29 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 26529100